osteoarthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The subjects voluntarily agree to participate in the study and sign a written informed consent; (2) Age 18-75 years old, male or female; (3) Clinically diagnosed patients with osteoarthritis; (4) No previous bleeding, asthma, severe cardiac, liver and renal insufficiency, non-steroidal drug allergy history; (5) The study/control drugs used by the patient were included in the drug list specified in this study.
Exclusion criteria
Exclusion criteria: (1) previous treatment that may affect the efficacy; (2) Patients with open wounds, scars or ulcers in the gel paste application area; (3) fracture, dislocation, etc.; Accompanied by tumors, cardiovascular and cerebrovascular diseases, blood diseases and other serious primary diseases, or accompanied by mental disorders and communication disorders can not determine the efficacy. Radiating pain or dysfunction caused by other diseases (visceral organ diseases, cardiovascular and cerebrovascular diseases); (4) Pregnant and lactating women or women of childbearing age who are trying to conceive; (5) Other situations in which the researcher considers it inappropriate to participate in this experiment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS;WOMAC;Lysholm; | — |
Countries
China
Contacts
The Third Affiliated Hospital of Southern Medical University